Clinical Trials Logo

Ovarian Endometrioid Tumor clinical trials

View clinical trials related to Ovarian Endometrioid Tumor.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05226507 Recruiting - Ovarian Cancer Clinical Trials

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Start date: December 31, 2021
Phase: Phase 1
Study type: Interventional

The purpose of the dose escalation phase is to evaluate the safety profile of escalating doses and dose schedules of NXP800. In the expansion phase the preliminary efficacy in subjects with ARID1a mutated ovarian clear cell and ovarian endometrioid cancers will be estimated.